Skip to content
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Visit
Home
(current)
Diseases
Alzheimer's Disease
Dementia
Dementia with Lewy Bodies
Frontotemporal Dementia
Vascular Dementia
Mild Cognitive Impairment
View all Diseases
Topics
Diagnostics
Biology
Communication
Treatment
Care Practice
Prevention
View all Topics
Conferences
CTAD 2022
AAIC 2022
EAN 2022
ESOC 2022
AAN 2022
CONy 2022
View all Conferences
Features
Podcasts
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Alzheimer’s Disease
1:58
The value of plasma p-tau181 as a screening and diagnostic tool for Alzheimer’s disease
Milica Kramberger
• 21 Nov 2022
1:52
The future of SAGE-718 in Alzheimer’s disease treatment
Aaron Koenig
• 28 Nov 2022
1:30
Understanding the effect of other diseases on blood biomarker levels in AD
Milica Kramberger
• 21 Nov 2022
4:11
The impact of TKIs on miRNA expression in the treatment of AD
Charbel Moussa
• 2 Dec 2022
2:28
Use of machine learning in Alzheimer’s disease
Irene Cumplido-Mayoral
• 25 Nov 2022
2:55
APOEε4 carriership combined with Aβ positivity for AD clinical trial enrichment
João Pedro Ferrari-Souza
• 25 Nov 2022
1:17
Potential value of p-tau181 and NfL for clinical trial pre-screening
João Pedro Ferrari-Souza
• 25 Nov 2022
1:37
Therapeutic potential of omega-3 supplementation in slowing cognitive decline for APOE4 carriers
Hussein Yassine
• 30 Nov 2022
6:13
Biomarkers for early detection of Alzheimer’s disease: microRNAs
Bruno Steinkraus
• 1 Dec 2022
1:42
Insights into the upcoming LIGHTWAVE trial using SAGE-718 to treat patients with MCI and early AD
Aaron Koenig
• 28 Nov 2022
4:39
The COCOA Trial: can multimodal lifestyle interventions treat AD?
Jared Roach
• 22 Nov 2022
5:28
Systemic inflammation and reduced cerebral Aβ clearance triggered by pancreatic amylin
Florin Despa
• 28 Nov 2022
1:00
New mechanisms to treat Alzheimer’s disease by targeting the NMDA pathway
Aaron Koenig
• 28 Nov 2022
4:37
Long-term transdermal nicotine for the treatment of mild cognitive impairment
Paul Newhouse
• 23 Nov 2022
1:26
The role of p53 in the pathogenesis of Alzheimer’s disease
Paul Kinnon
• 28 Nov 2022
3:06
The PreventE4 study: testing omega-3 supplementation in APOE4 carriers before the onset of dementia
Hussein Yassine
• 30 Nov 2022
Previous
1
2
3
4
5
6
7
8
…
47
Next